← Open Payments lookup

BRIAN SZELC: Open Payments

NPI 1225451750 · NESHANNOCK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,043 in 88 payments from 15 companies in 2025. Trend: 2023 $966 · 2024 $1,595 · 2025 $2,043

Food & beverage: $1,899Education: $144
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.12$332
ABBVIE INC.21$323
Tris Pharma Inc6$313
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$215
Janssen Pharmaceuticals, Inc6$158
E.R. Squibb & Sons, L.L.C.3$140
Axsome Therapeutics, Inc.4$109
Otsuka America Pharmaceutical, Inc.5$97
Lundbeck LLC5$95
Neurocrine BioSciences, Inc.4$82

Products named: VRAYLAR, Dyanavel XR, CAPLYTA, REXULTI, SPRAVATO, COBENFY, AUSTEDO XR, Auvelity.

Industry payments across PA — which companies pay providers there.